| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ephrin receptor activity | 1.58e-05 | 19 | 165 | 4 | GO:0005003 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 1.89e-05 | 7 | 165 | 3 | GO:0005004 | |
| GeneOntologyMolecularFunction | ATP-dependent DNA damage sensor activity | 1.96e-05 | 20 | 165 | 4 | GO:0140664 | |
| GeneOntologyMolecularFunction | DNA damage sensor activity | 4.20e-05 | 24 | 165 | 4 | GO:0140612 | |
| GeneOntologyMolecularFunction | calcium ion binding | LPCAT1 PCDHGB6 PCDHGB5 ANXA7 SPOCK2 CUBN SYT10 RYR1 THBS1 PPP3R1 SPOCK3 PITPNM3 CPNE1 MACF1 C1S LTBP2 CDH2 PCDH7 | 4.96e-05 | 749 | 165 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 7.41e-05 | 85 | 165 | 6 | GO:0019199 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.73e-04 | 188 | 165 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.01e-04 | 65 | 165 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 2.34e-04 | 15 | 165 | 3 | GO:0005005 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.13e-04 | 18 | 165 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 6.88e-04 | 231 | 165 | 8 | GO:0005085 | |
| GeneOntologyMolecularFunction | molecular sensor activity | 7.70e-04 | 50 | 165 | 4 | GO:0140299 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring compression resistance | 8.69e-04 | 23 | 165 | 3 | GO:0030021 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FLNA FLNB ABCF3 ANXA7 OBSCN ITGAL MPRIP POSTN THBS1 PTPRD MACF1 FGFR1 CDH2 | 1.45e-03 | 599 | 165 | 13 | GO:0050839 |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB3 MYLK KALRN STK17A NTRK3 OBSCN ELP1 SRPK1 BMPR1B HASPIN FGFR1 EPHA5 EPHA7 | 1.47e-03 | 600 | 165 | 13 | GO:0004672 |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 1.53e-03 | 60 | 165 | 4 | GO:0005544 | |
| GeneOntologyMolecularFunction | kinase activity | EPHB3 PMS2P1 MYLK KALRN STK17A NTRK3 OBSCN ELP1 SRPK1 PMS2P11 BMPR1B HASPIN FGFR1 EPHA5 EPHA7 | 1.71e-03 | 764 | 165 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | ATP-dependent activity | RAD51C PMS2P1 TTF2 PMS2P3 PMS2 ABCF3 DNAH10 CCT7 NUBP2 MACF1 ATP2B1 DNAH9 KIF25 | 1.81e-03 | 614 | 165 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | rRNA (adenine) methyltransferase activity | 1.84e-03 | 8 | 165 | 2 | GO:0016433 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.90e-03 | 156 | 165 | 6 | GO:0019838 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB3 PMS2P1 CTU2 MYLK KALRN STK17A NTRK3 OBSCN ELP1 SRPK1 PMS2P11 BMPR1B HASPIN FGFR1 EPHA5 EPHA7 PARP15 | 2.00e-03 | 938 | 165 | 17 | GO:0016772 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | EPHB3 HGF FLNA KALRN WNT3 NTRK3 GRN FZD1 PTPRD PTPRS STAU2 MACF1 FGFR1 CDH2 PREX1 PLXNA2 PLXNB1 EPHA7 | 1.48e-06 | 612 | 161 | 18 | GO:0010975 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB3 HGF FLNA FLNB KALRN WNT3 NTRK3 ANXA7 SIPA1L3 PECAM1 ALS2 PDZD7 STRIP1 POSTN BMPR1B PTPRD PTPRS STAU2 CPNE1 MACF1 CDH2 PLXNA2 PLXNB1 EPHA5 EPHA7 | 6.12e-06 | 1194 | 161 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection regeneration | 1.00e-05 | 18 | 161 | 4 | GO:0070572 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 2.06e-05 | 192 | 161 | 9 | GO:0050770 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB3 HGF FLNA KALRN WNT3 NTRK3 ALS2 GRN PDZD7 PHGDH FZD1 POSTN BMPR1B PTPRD PTPRS STAU2 CPNE1 MACF1 FGFR1 CDH2 PREX1 PLXNA2 PLXNB1 EPHA5 EPHA7 | 2.14e-05 | 1285 | 161 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | synapse organization | EPHB3 FLNA CTTNBP2 KALRN NTRK3 SPOCK2 ALS2 GRN FZD1 PTPRD PTPRS STAU2 FGFR1 CDH2 PLXNB1 EPHA5 EPHA7 | 2.68e-05 | 685 | 161 | 17 | GO:0050808 |
| GeneOntologyBiologicalProcess | synapse assembly | EPHB3 NTRK3 SPOCK2 FZD1 PTPRD PTPRS STAU2 FGFR1 CDH2 PLXNB1 EPHA7 | 3.15e-05 | 308 | 161 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | regulation of neuron projection regeneration | 3.20e-05 | 47 | 161 | 5 | GO:0070570 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 3.79e-05 | 9 | 161 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density organization | 5.46e-05 | 27 | 161 | 4 | GO:1905874 | |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB3 FLNA CTTNBP2 KALRN NTRK3 PECAM1 SPOCK2 ALS2 GRN FZD1 THBS1 PTPRD PTPRS STAU2 MACF1 FGFR1 CDH2 PLXNB1 EPHA5 EPHA7 | 7.45e-05 | 974 | 161 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 8.93e-05 | 58 | 161 | 5 | GO:0097106 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EPHB3 HGF FLNA KALRN WNT3 NTRK3 GRN FZD1 PTPRD PTPRS STAU2 MACF1 FGFR1 CDH2 PREX1 PLXNA2 PLXNB1 EPHA7 | 1.12e-04 | 846 | 161 | 18 | GO:0120035 |
| GeneOntologyBiologicalProcess | dendritic spine development | 1.22e-04 | 141 | 161 | 7 | GO:0060996 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 1.38e-04 | 34 | 161 | 4 | GO:0097107 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | HGF FLNA KALRN WNT3 NTRK3 GRN FZD1 PTPRD STAU2 MACF1 FGFR1 PLXNA2 PLXNB1 | 1.39e-04 | 494 | 161 | 13 | GO:0031346 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EPHB3 HGF FLNA KALRN WNT3 NTRK3 GRN FZD1 PTPRD PTPRS STAU2 MACF1 FGFR1 CDH2 PREX1 PLXNA2 PLXNB1 EPHA7 | 1.44e-04 | 863 | 161 | 18 | GO:0031344 |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 1.53e-04 | 249 | 161 | 9 | GO:0010976 | |
| GeneOntologyBiologicalProcess | cell junction assembly | EPHB3 NTRK3 PECAM1 SPOCK2 FZD1 THBS1 PTPRD PTPRS STAU2 MACF1 FGFR1 CDH2 PLXNB1 EPHA7 | 1.55e-04 | 569 | 161 | 14 | GO:0034329 |
| GeneOntologyBiologicalProcess | axon development | EPHB3 FLNA KALRN WNT3 NTRK3 ALS2 GRN BMPR1B PTPRS MACF1 CDH2 PLXNA2 PLXNB1 EPHA5 EPHA7 | 1.58e-04 | 642 | 161 | 15 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 1.63e-04 | 309 | 161 | 10 | GO:1901888 | |
| GeneOntologyBiologicalProcess | neuron development | EPHB3 HGF FLNA KALRN WNT3 NTRK3 ALS2 GRN PDZD7 PHGDH FZD1 POSTN BMPR1B PTPRD PTPRS STAU2 CPNE1 MACF1 FGFR1 CDH2 PREX1 PLXNA2 PLXNB1 EPHA5 EPHA7 | 1.72e-04 | 1463 | 161 | 25 | GO:0048666 |
| GeneOntologyBiologicalProcess | tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation | 1.81e-04 | 3 | 161 | 2 | GO:0002926 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation | 1.81e-04 | 3 | 161 | 2 | GO:0044338 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 1.81e-04 | 313 | 161 | 10 | GO:0099173 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB3 KALRN WNT3 NTRK3 ALS2 POSTN BMPR1B PTPRD PTPRS STAU2 CPNE1 MACF1 CDH2 PLXNA2 PLXNB1 EPHA5 EPHA7 | 1.84e-04 | 802 | 161 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 1.92e-04 | 202 | 161 | 8 | GO:0051963 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 2.34e-04 | 71 | 161 | 5 | GO:0099084 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB3 KALRN WNT3 NTRK3 ALS2 POSTN BMPR1B PTPRD PTPRS STAU2 CPNE1 MACF1 CDH2 PLXNA2 PLXNB1 EPHA5 EPHA7 | 2.35e-04 | 819 | 161 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | EPHB3 CTTNBP2 KALRN NTRK3 FZD1 PTPRD PTPRS STAU2 FGFR1 CDH2 EPHA7 | 2.38e-04 | 387 | 161 | 11 | GO:0050807 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB3 KALRN WNT3 NTRK3 ALS2 PDZD7 BMPR1B PTPRD PTPRS STAU2 MACF1 CDH2 PLXNA2 PLXNB1 EPHA5 EPHA7 | 2.59e-04 | 748 | 161 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB3 KALRN WNT3 NTRK3 ALS2 POSTN BMPR1B PTPRD PTPRS STAU2 CPNE1 MACF1 CDH2 PLXNA2 PLXNB1 EPHA5 EPHA7 | 2.59e-04 | 826 | 161 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of axon regeneration | 2.63e-04 | 40 | 161 | 4 | GO:0048679 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | EPHB3 CTTNBP2 KALRN NTRK3 FZD1 PTPRD PTPRS STAU2 FGFR1 CDH2 EPHA7 | 2.83e-04 | 395 | 161 | 11 | GO:0050803 |
| GeneOntologyBiologicalProcess | positive regulation of axon regeneration | 2.93e-04 | 17 | 161 | 3 | GO:0048680 | |
| GeneOntologyBiologicalProcess | tRNA wobble uridine modification | 2.93e-04 | 17 | 161 | 3 | GO:0002098 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | EPHB3 KALRN NTRK3 ALS2 DENND1B PREX1 PBXIP1 PLXNA2 PLXNB1 EPHA5 | 3.11e-04 | 335 | 161 | 10 | GO:0043087 |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 3.81e-04 | 44 | 161 | 4 | GO:0098698 | |
| GeneOntologyBiologicalProcess | neuron projection regeneration | 4.33e-04 | 81 | 161 | 5 | GO:0031102 | |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 4.33e-04 | 81 | 161 | 5 | GO:0060997 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 4.52e-04 | 46 | 161 | 4 | GO:1904861 | |
| GeneOntologyBiologicalProcess | tRNA wobble base modification | 4.83e-04 | 20 | 161 | 3 | GO:0002097 | |
| GeneOntologyBiologicalProcess | lateral mesoderm development | 4.83e-04 | 20 | 161 | 3 | GO:0048368 | |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB3 KALRN WNT3 NTRK3 ALS2 BMPR1B PTPRS MACF1 CDH2 PLXNA2 PLXNB1 EPHA5 EPHA7 | 5.14e-04 | 566 | 161 | 13 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | EPHB3 KALRN NTRK3 SPOCK2 ALS2 GRN THBS1 DENND1B SPOCK3 ANTXR1 FGFR1 PREX1 PBXIP1 PLXNA2 PLXNB1 EPHA5 EPHA7 | 5.22e-04 | 878 | 161 | 17 | GO:0051336 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density assembly | 5.60e-04 | 21 | 161 | 3 | GO:0099151 | |
| GeneOntologyBiologicalProcess | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | 5.96e-04 | 5 | 161 | 2 | GO:0060665 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 6.37e-04 | 185 | 161 | 7 | GO:0099175 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 7.38e-04 | 91 | 161 | 5 | GO:0060998 | |
| GeneOntologyBiologicalProcess | positive regulation of response to wounding | 8.14e-04 | 93 | 161 | 5 | GO:1903036 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 8.14e-04 | 93 | 161 | 5 | GO:0099068 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 8.35e-04 | 54 | 161 | 4 | GO:0048013 | |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 8.38e-04 | 24 | 161 | 3 | GO:0031290 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | EPHB3 HGF KALRN WNT3 NTRK3 ANXA7 GRN STRIP1 FZD1 THBS1 PTPRD PTPRS STAU2 MACF1 FGFR1 CDH2 PLXNA2 PLXNB1 EPHA7 | 8.74e-04 | 1090 | 161 | 19 | GO:0022603 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 3.85e-05 | 9 | 164 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | extracellular matrix | LAMB4 COL12A1 WNT3 ANXA7 SPOCK2 CHADL SSPOP POSTN THBS1 SPOCK3 HPX PODN LTBP2 MMP17 CDH2 PLXNA2 | 6.13e-05 | 656 | 164 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMB4 COL12A1 WNT3 ANXA7 SPOCK2 CHADL SSPOP POSTN THBS1 SPOCK3 HPX PODN LTBP2 MMP17 CDH2 PLXNA2 | 6.36e-05 | 658 | 164 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | mismatch repair complex | 7.47e-05 | 11 | 164 | 3 | GO:0032300 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.62e-04 | 14 | 164 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LAMB4 COL12A1 ANXA7 SPOCK2 CHADL SSPOP POSTN THBS1 HPX PODN LTBP2 CDH2 PLXNA2 | 2.90e-04 | 530 | 164 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | glutamatergic synapse | FLNA CNNM2 CTTNBP2 KALRN NTRK3 ALS2 GRN SYT10 PTPRD PPP3R1 PTPRS FGFR1 CPSF2 CDH2 ATP2B1 EPHA7 | 7.18e-04 | 817 | 164 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | elongator holoenzyme complex | 8.99e-04 | 6 | 164 | 2 | GO:0033588 | |
| HumanPheno | Eruption failure | 1.51e-05 | 17 | 48 | 4 | HP:0000706 | |
| Domain | - | EPHB3 FLNA FLNB COL12A1 MYLK KALRN NTRK3 PECAM1 OBSCN IGDCC3 TGM6 NOMO1 PTPRD NOMO2 PTPRS FGFR1 PLXNA2 NOMO3 PLXNB1 EPHA5 EPHA7 | 2.46e-07 | 663 | 160 | 21 | 2.60.40.10 |
| Domain | Ig-like_fold | EPHB3 FLNA FLNB COL12A1 MYLK KALRN NTRK3 PECAM1 OBSCN IGDCC3 TGM6 NOMO1 PTPRD NOMO2 PTPRS FGFR1 PLXNA2 NOMO3 PLXNB1 EPHA5 EPHA7 | 6.85e-07 | 706 | 160 | 21 | IPR013783 |
| Domain | fn3 | EPHB3 COL12A1 MYLK KALRN OBSCN IGDCC3 PTPRD PTPRS EPHA5 EPHA7 | 1.36e-06 | 162 | 160 | 10 | PF00041 |
| Domain | DUF2012 | 2.45e-06 | 4 | 160 | 3 | PF09430 | |
| Domain | DUF2012 | 2.45e-06 | 4 | 160 | 3 | IPR019008 | |
| Domain | FN3 | EPHB3 COL12A1 MYLK KALRN OBSCN IGDCC3 PTPRD PTPRS EPHA5 EPHA7 | 4.49e-06 | 185 | 160 | 10 | SM00060 |
| Domain | FN3 | EPHB3 COL12A1 MYLK KALRN OBSCN IGDCC3 PTPRD PTPRS EPHA5 EPHA7 | 8.56e-06 | 199 | 160 | 10 | PS50853 |
| Domain | FN3_dom | EPHB3 COL12A1 MYLK KALRN OBSCN IGDCC3 PTPRD PTPRS EPHA5 EPHA7 | 1.31e-05 | 209 | 160 | 10 | IPR003961 |
| Domain | Carb-bd-like_fold | 3.35e-05 | 8 | 160 | 3 | IPR013784 | |
| Domain | - | 3.81e-05 | 73 | 160 | 6 | 2.60.120.260 | |
| Domain | VWFA | 7.36e-05 | 82 | 160 | 6 | PS50234 | |
| Domain | VWA | 8.43e-05 | 84 | 160 | 6 | SM00327 | |
| Domain | Protein_kinase_ATP_BS | EPHB3 MYLK KALRN STK17A NTRK3 OBSCN SRPK1 BMPR1B HASPIN FGFR1 EPHA5 EPHA7 | 1.07e-04 | 379 | 160 | 12 | IPR017441 |
| Domain | Pkinase_Tyr | 1.24e-04 | 129 | 160 | 7 | PF07714 | |
| Domain | Galactose-bd-like | 1.57e-04 | 94 | 160 | 6 | IPR008979 | |
| Domain | CarboxyPept_regulatory_dom | 1.66e-04 | 13 | 160 | 3 | IPR014766 | |
| Domain | - | 1.66e-04 | 13 | 160 | 3 | 2.60.40.1120 | |
| Domain | PROTEIN_KINASE_TYR | 1.87e-04 | 97 | 160 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.87e-04 | 97 | 160 | 6 | IPR008266 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.88e-04 | 138 | 160 | 7 | IPR001245 | |
| Domain | DH_1 | 2.04e-04 | 63 | 160 | 5 | PS00741 | |
| Domain | VWF_A | 2.09e-04 | 99 | 160 | 6 | IPR002035 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 2.10e-04 | 14 | 160 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 2.10e-04 | 14 | 160 | 3 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 2.10e-04 | 14 | 160 | 3 | IPR001426 | |
| Domain | EphA2_TM | 2.10e-04 | 14 | 160 | 3 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 2.10e-04 | 14 | 160 | 3 | IPR001090 | |
| Domain | Eph_TM | 2.10e-04 | 14 | 160 | 3 | IPR027936 | |
| Domain | EPH_lbd | 2.10e-04 | 14 | 160 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 2.10e-04 | 14 | 160 | 3 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 2.10e-04 | 14 | 160 | 3 | IPR016257 | |
| Domain | EPH_LBD | 2.10e-04 | 14 | 160 | 3 | PS51550 | |
| Domain | Ig_I-set | 2.37e-04 | 190 | 160 | 8 | IPR013098 | |
| Domain | I-set | 2.37e-04 | 190 | 160 | 8 | PF07679 | |
| Domain | RhoGEF | 3.35e-04 | 70 | 160 | 5 | PF00621 | |
| Domain | DH_2 | 3.35e-04 | 70 | 160 | 5 | PS50010 | |
| Domain | - | 3.58e-04 | 71 | 160 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 3.58e-04 | 71 | 160 | 5 | IPR000219 | |
| Domain | CarboxyPept-like_regulatory | 3.84e-04 | 17 | 160 | 3 | IPR008969 | |
| Domain | Peptidase_S1A | 4.27e-04 | 113 | 160 | 6 | IPR001314 | |
| Domain | - | 4.33e-04 | 4 | 160 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 4.33e-04 | 4 | 160 | 2 | PS51139 | |
| Domain | GTF2I | 4.33e-04 | 4 | 160 | 2 | PF02946 | |
| Domain | GTF2I | 4.33e-04 | 4 | 160 | 2 | IPR004212 | |
| Domain | TRYPSIN_DOM | 4.69e-04 | 115 | 160 | 6 | PS50240 | |
| Domain | Tryp_SPc | 5.14e-04 | 117 | 160 | 6 | SM00020 | |
| Domain | PROTEIN_KINASE_ATP | EPHB3 MYLK KALRN STK17A NTRK3 OBSCN SRPK1 BMPR1B HASPIN FGFR1 EPHA5 EPHA7 | 6.09e-04 | 459 | 160 | 12 | PS00107 |
| Domain | Trypsin_dom | 6.15e-04 | 121 | 160 | 6 | IPR001254 | |
| Domain | Trypsin | 6.15e-04 | 121 | 160 | 6 | PF00089 | |
| Domain | RCC1 | 6.32e-04 | 20 | 160 | 3 | PF00415 | |
| Domain | Peptidase_S1_PA | 6.70e-04 | 123 | 160 | 6 | IPR009003 | |
| Domain | RCC1_1 | 7.33e-04 | 21 | 160 | 3 | PS00625 | |
| Domain | RCC1_2 | 7.33e-04 | 21 | 160 | 3 | PS00626 | |
| Domain | RCC1_3 | 7.33e-04 | 21 | 160 | 3 | PS50012 | |
| Domain | Kinase-like_dom | EPHB3 MYLK KALRN STK17A NTRK3 OBSCN SRPK1 BMPR1B HASPIN MACF1 FGFR1 EPHA5 EPHA7 | 8.08e-04 | 542 | 160 | 13 | IPR011009 |
| Domain | - | 8.43e-04 | 22 | 160 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 8.43e-04 | 22 | 160 | 3 | IPR000408 | |
| Domain | Tyr_kinase_cat_dom | 9.58e-04 | 88 | 160 | 5 | IPR020635 | |
| Domain | TyrKc | 9.58e-04 | 88 | 160 | 5 | SM00219 | |
| Domain | ACTININ_2 | 9.63e-04 | 23 | 160 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.63e-04 | 23 | 160 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.63e-04 | 23 | 160 | 3 | IPR001589 | |
| Domain | RCC1/BLIP-II | 9.63e-04 | 23 | 160 | 3 | IPR009091 | |
| Domain | IGc2 | 9.66e-04 | 235 | 160 | 8 | SM00408 | |
| Domain | Ig_sub2 | 9.66e-04 | 235 | 160 | 8 | IPR003598 | |
| Domain | Prot_kinase_dom | EPHB3 MYLK KALRN STK17A NTRK3 OBSCN SRPK1 BMPR1B HASPIN FGFR1 EPHA5 EPHA7 | 1.05e-03 | 489 | 160 | 12 | IPR000719 |
| Domain | TRYPSIN_SER | 1.06e-03 | 90 | 160 | 5 | IPR033116 | |
| Domain | PROTEIN_KINASE_DOM | EPHB3 MYLK KALRN STK17A NTRK3 OBSCN SRPK1 BMPR1B HASPIN FGFR1 EPHA5 EPHA7 | 1.13e-03 | 493 | 160 | 12 | PS50011 |
| Domain | Ephrin_rec_like | 1.24e-03 | 25 | 160 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.24e-03 | 25 | 160 | 3 | IPR011641 | |
| Domain | ig | 1.27e-03 | 190 | 160 | 7 | PF00047 | |
| Domain | Immunoglobulin | 1.27e-03 | 190 | 160 | 7 | IPR013151 | |
| Domain | VWA | 1.35e-03 | 56 | 160 | 4 | PF00092 | |
| Domain | Znf_GRF | 1.49e-03 | 7 | 160 | 2 | IPR010666 | |
| Domain | zf-GRF | 1.49e-03 | 7 | 160 | 2 | PF06839 | |
| Domain | TRYPSIN_HIS | 1.93e-03 | 103 | 160 | 5 | IPR018114 | |
| Domain | SPARC/Testican_Ca-bd-dom | 1.97e-03 | 8 | 160 | 2 | IPR019577 | |
| Domain | DHC_N1 | 1.97e-03 | 8 | 160 | 2 | PF08385 | |
| Domain | SPARC_Ca_bdg | 1.97e-03 | 8 | 160 | 2 | PF10591 | |
| Domain | Dynein_heavy_dom-1 | 1.97e-03 | 8 | 160 | 2 | IPR013594 | |
| Domain | Ig_E-set | 2.02e-03 | 104 | 160 | 5 | IPR014756 | |
| Domain | EGF_2 | 2.07e-03 | 265 | 160 | 8 | PS01186 | |
| Domain | TRYPSIN_SER | 2.19e-03 | 106 | 160 | 5 | PS00135 | |
| Domain | TRYPSIN_HIS | 2.28e-03 | 107 | 160 | 5 | PS00134 | |
| Domain | Copine | 2.52e-03 | 9 | 160 | 2 | PF07002 | |
| Domain | Plexin_cytopl | 2.52e-03 | 9 | 160 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 2.52e-03 | 9 | 160 | 2 | IPR013548 | |
| Domain | Plexin | 2.52e-03 | 9 | 160 | 2 | IPR031148 | |
| Domain | Copine | 2.52e-03 | 9 | 160 | 2 | IPR010734 | |
| Domain | RhoGEF | 2.76e-03 | 68 | 160 | 4 | SM00325 | |
| Domain | IG_FLMN | 3.14e-03 | 10 | 160 | 2 | SM00557 | |
| Domain | Filamin | 3.81e-03 | 11 | 160 | 2 | PF00630 | |
| Domain | Ephrin_rec_like | 3.81e-03 | 11 | 160 | 2 | PF07699 | |
| Domain | Frizzled | 3.81e-03 | 11 | 160 | 2 | IPR000539 | |
| Domain | Frizzled | 3.81e-03 | 11 | 160 | 2 | PF01534 | |
| Domain | FILAMIN_REPEAT | 3.81e-03 | 11 | 160 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 3.81e-03 | 11 | 160 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 3.81e-03 | 11 | 160 | 2 | IPR017868 | |
| Domain | Frizzled | 3.81e-03 | 11 | 160 | 2 | SM01330 | |
| Domain | GDS_CDC24_CS | 4.50e-03 | 39 | 160 | 3 | IPR001331 | |
| Pubmed | 1.12e-09 | 11 | 168 | 5 | 8586419 | ||
| Pubmed | 5.22e-09 | 257 | 168 | 12 | 16335952 | ||
| Pubmed | 6.10e-09 | 117 | 168 | 9 | 17145500 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.11e-07 | 3 | 168 | 3 | 25576386 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 4.41e-07 | 4 | 168 | 3 | 31833031 | |
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 9267806 | ||
| Pubmed | FLNB COL12A1 CTTNBP2 CAND2 KALRN OBSCN ELP1 KMT2E PHGDH RYR1 INTS4 MACF1 OS9 | 1.01e-06 | 497 | 168 | 13 | 23414517 | |
| Pubmed | 1.10e-06 | 5 | 168 | 3 | 17360453 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNA FLNB CNNM2 CAND2 ELP1 SRPK1 CCT7 PAAF1 ELP3 SLC1A5 NOMO1 PTPRD PTPRS OS9 ANKMY2 HECTD1 ATP2B1 WDR77 | 1.29e-06 | 974 | 168 | 18 | 28675297 |
| Pubmed | 1.78e-06 | 75 | 168 | 6 | 20637190 | ||
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 1.82e-06 | 42 | 168 | 5 | 11439183 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA KALRN SIPA1L3 OBSCN EML2 TMCO6 FBXO46 SLC1A5 RYR1 MPRIP FZD1 MROH1 PTPRS AKAP13 WDR90 FGFR1 MMP17 HECTD1 PREX1 | 1.86e-06 | 1105 | 168 | 19 | 35748872 |
| Pubmed | 2.35e-06 | 175 | 168 | 8 | 28071719 | ||
| Pubmed | PMS2 SAAL1 SIPA1L3 ELP1 CCT7 RCC1 BCKDHB PAAF1 ELP3 SLC1A5 POSTN PTPRD PPP3R1 PTPRS INTS4 CPSF2 ATP2B1 PCDH7 | 3.63e-06 | 1049 | 168 | 18 | 27880917 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.64e-06 | 248 | 168 | 9 | 24006456 | |
| Pubmed | 3.82e-06 | 7 | 168 | 3 | 7980603 | ||
| Pubmed | 3.84e-06 | 132 | 168 | 7 | 26439863 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | FLNA FLNB CPNE8 ANXA7 LAMP1 GRN CUBN CFI PHGDH THBS1 PTPRD PTPRS BTD HPX CPNE1 C2 LTBP2 GAA | 4.77e-06 | 1070 | 168 | 18 | 23533145 |
| Pubmed | FLNA FLNB CTU2 COL12A1 POLD2 ANXA7 LAMP1 SRPK1 CCT7 SLC1A5 PHGDH NOMO2 ANTXR1 MACF1 OS9 AKAP13 BOD1L1 HECTD1 HERC4 GAA | 5.04e-06 | 1297 | 168 | 20 | 33545068 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 5.59e-06 | 333 | 168 | 10 | 32665550 | |
| Pubmed | A TrkB/EphrinA interaction controls retinal axon branching and synaptogenesis. | 6.09e-06 | 8 | 168 | 3 | 19036963 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 6.09e-06 | 8 | 168 | 3 | 15257293 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL12A1 LAMP1 GRN NOMO1 FZD6 THBS1 NOMO2 PTPRS BTD ANTXR1 LTBP2 CPSF2 HECTD1 CDH2 ATP2B1 PCDH7 DCBLD2 PBXIP1 PLXNB1 | 6.15e-06 | 1201 | 168 | 19 | 35696571 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 6.77e-06 | 202 | 168 | 8 | 33005030 | |
| Pubmed | 9.10e-06 | 9 | 168 | 3 | 11403717 | ||
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 9.10e-06 | 9 | 168 | 3 | 36261522 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 9.63e-06 | 212 | 168 | 8 | 33853758 | |
| Pubmed | HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia. | 1.30e-05 | 10 | 168 | 3 | 17304517 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FLNB LAMB4 SELENOW OBSCN IGDCC3 GRN ZNF831 SSPOP RYR1 R3HCC1L BTD PITPNM3 AKAP13 BOD1L1 | 1.50e-05 | 736 | 168 | 14 | 29676528 |
| Pubmed | 1.78e-05 | 11 | 168 | 3 | 25624497 | ||
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.78e-05 | 11 | 168 | 3 | 32820719 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 1.88e-05 | 67 | 168 | 5 | 21875946 | |
| Pubmed | Molecular and spatial landmarks of early mouse skin development. | 1.93e-05 | 33 | 168 | 4 | 37591247 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KLHDC2 NTRK3 SIPA1L3 ALS2 SLC1A5 MPRIP ARFGEF3 DENND1B MACF1 AKAP13 BOD1L1 RNF180 HECTD1 ATP2B1 PCDH7 | 2.05e-05 | 861 | 168 | 15 | 36931259 |
| Pubmed | FLNA FLNB PMS2 SAAL1 CAND2 ABCF3 POLD2 OBSCN SPOCK2 ALS2 CUBN MACF1 BOD1L1 CPSF2 ATP2B1 HERC4 PLXNB1 | 2.18e-05 | 1084 | 168 | 17 | 11544199 | |
| Pubmed | FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors. | 2.32e-05 | 2 | 168 | 2 | 27974047 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19959938 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15672414 | ||
| Pubmed | Alteration of HGF and TSP-1 expression in ovarian carcinoma associated with clinical features. | 2.32e-05 | 2 | 168 | 2 | 22136730 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 28951524 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 28754779 | ||
| Pubmed | Essential role of obscurin kinase-1 in cardiomyocyte coupling via N-cadherin phosphorylation. | 2.32e-05 | 2 | 168 | 2 | 38127465 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 27030285 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21262467 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17635842 | ||
| Pubmed | Molecular cloning and nucleotide sequence of human pancreatic prechymotrypsinogen cDNA. | 2.32e-05 | 2 | 168 | 2 | 2917002 | |
| Pubmed | Genomic cloning and partial characterization of human chymotrypsinogen gene. | 2.32e-05 | 2 | 168 | 2 | 8186414 | |
| Pubmed | Filamin depletion blocks endoplasmic spreading and destabilizes force-bearing adhesions. | 2.32e-05 | 2 | 168 | 2 | 21325628 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17060446 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 20652947 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15077197 | ||
| Pubmed | Chymotrypsin Reduces the Severity of Secretagogue-Induced Pancreatitis in Mice. | 2.32e-05 | 2 | 168 | 2 | 30076839 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 23696512 | ||
| Pubmed | Sequencing of the complex CTRB1-CTRB2 locus in chronic pancreatitis. | 2.32e-05 | 2 | 168 | 2 | 33036922 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 2565717 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 11336782 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 33649519 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 36906610 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 31312021 | ||
| Pubmed | Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations. | 2.32e-05 | 2 | 168 | 2 | 25154786 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 9566880 | ||
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 2.32e-05 | 2 | 168 | 2 | 15388857 | |
| Pubmed | 2.36e-05 | 12 | 168 | 3 | 36399562 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | LPCAT1 CNNM2 CTTNBP2 CAND2 ELP1 CCT7 GRN BCKDHB ELP3 STRIP1 INTS4 ATP2B1 | 2.46e-05 | 573 | 168 | 12 | 28330616 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | PMS2P1 FLNA FLNB LPCAT1 SRPK1 CUBN SLC1A5 PHGDH NOMO1 CPNE1 CRYZL1 CPSF2 NOMO3 | 2.48e-05 | 670 | 168 | 13 | 22990118 |
| Pubmed | 2.74e-05 | 36 | 168 | 4 | 24151333 | ||
| Pubmed | 2.78e-05 | 320 | 168 | 9 | 28685749 | ||
| Pubmed | 3.06e-05 | 13 | 168 | 3 | 23277359 | ||
| Pubmed | 3.06e-05 | 13 | 168 | 3 | 12923052 | ||
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 3.41e-05 | 38 | 168 | 4 | 11756498 | |
| Pubmed | CPNE8 CAND2 ELP1 SRPK1 RCC1 BCKDHB SLC1A5 MPRIP NOMO1 TUBGCP6 R3HCC1L NOMO2 STAU2 MACF1 OS9 AKAP13 ATP2B1 PCDH7 PBXIP1 EPHA7 | 3.59e-05 | 1487 | 168 | 20 | 33957083 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RAD51C TTF2 CAND2 POLD2 ELP1 CCT7 ELP3 SLC1A5 PHGDH NUBP2 NOMO1 TRMT2A NOMO2 NUP37 CPSF2 HECTD1 WDR77 NOMO3 | 4.07e-05 | 1257 | 168 | 18 | 37317656 |
| Pubmed | 4.19e-05 | 40 | 168 | 4 | 30898150 | ||
| Pubmed | TTF2 CAND2 POLD2 ELP1 NUBP2 NOMO1 TUBGCP6 TRMT2A BRCA2 NOMO2 WDR77 NOMO3 | 4.22e-05 | 606 | 168 | 12 | 36538041 | |
| Pubmed | 4.22e-05 | 130 | 168 | 6 | 12421765 | ||
| Pubmed | 4.23e-05 | 191 | 168 | 7 | 33762435 | ||
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 4.43e-05 | 424 | 168 | 10 | 21731673 | |
| Pubmed | ABCF3 LAMP1 CCT7 GRN PHGDH NOMO1 NOMO2 PTPRS OS9 WDR77 GAA NOMO3 | 4.71e-05 | 613 | 168 | 12 | 22268729 | |
| Pubmed | 4.83e-05 | 15 | 168 | 3 | 18303054 | ||
| Pubmed | 5.31e-05 | 83 | 168 | 5 | 11114734 | ||
| Pubmed | FLNB PMS2 KALRN ANXA7 SIPA1L3 SPOCK2 CCT7 SEC31B MPRIP THBS1 PTPRD PPP3R1 NOMO2 MACF1 C1S HECTD1 PREX1 PBXIP1 | 5.40e-05 | 1285 | 168 | 18 | 35914814 | |
| Pubmed | 5.60e-05 | 43 | 168 | 4 | 12376548 | ||
| Pubmed | 5.60e-05 | 43 | 168 | 4 | 27664421 | ||
| Pubmed | Filamin A- and formin 2-dependent endocytosis regulates proliferation via the canonical Wnt pathway. | 5.92e-05 | 16 | 168 | 3 | 27789627 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | ANXA7 SIPA1L3 EML2 SRPK1 CCT7 KCTD1 PHGDH RYR1 NUBP2 KLHL22 STAU2 HPX EPHA7 | 6.13e-05 | 732 | 168 | 13 | 34732716 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 6.61e-05 | 358 | 168 | 9 | 32460013 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 17005551 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 38370408 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 39392048 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 28175289 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 32114392 | ||
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 6.94e-05 | 3 | 168 | 2 | 31985401 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 20139422 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 14555767 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 6.94e-05 | 3 | 168 | 2 | 33656439 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 1016231 | ||
| Pubmed | Cross-link regulation of precursor N-cadherin and FGFR1 by GDNF increases U251MG cell viability. | 6.94e-05 | 3 | 168 | 2 | 29750313 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 12393796 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 27988259 | ||
| GeneFamily | Fibronectin type III domain containing | EPHB3 COL12A1 MYLK KALRN OBSCN IGDCC3 PTPRD PTPRS EPHA5 EPHA7 | 3.74e-08 | 160 | 107 | 10 | 555 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.13e-06 | 161 | 107 | 8 | 593 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.43e-05 | 66 | 107 | 5 | 722 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 7.00e-05 | 14 | 107 | 3 | 1095 | |
| GeneFamily | Elongator acetyltransferase complex | 5.12e-04 | 6 | 107 | 2 | 539 | |
| GeneFamily | Zinc fingers GRF-type|Topoisomerases | 7.15e-04 | 7 | 107 | 2 | 135 | |
| GeneFamily | SPARC family | 9.49e-04 | 8 | 107 | 2 | 1278 | |
| GeneFamily | Copines | 1.22e-03 | 9 | 107 | 2 | 829 | |
| GeneFamily | Plexins | 1.22e-03 | 9 | 107 | 2 | 683 | |
| GeneFamily | Complement system|Sushi domain containing | 1.25e-03 | 36 | 107 | 3 | 492 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 1.84e-03 | 11 | 107 | 2 | 286 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.37e-03 | 394 | 107 | 8 | 471 | |
| GeneFamily | Dyneins, axonemal | 4.45e-03 | 17 | 107 | 2 | 536 | |
| GeneFamily | WD repeat domain containing | 4.67e-03 | 262 | 107 | 6 | 362 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 6.15e-03 | 20 | 107 | 2 | 548 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 6.15e-03 | 20 | 107 | 2 | 1371 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 6.77e-03 | 21 | 107 | 2 | 813 | |
| Coexpression | PILON_KLF1_TARGETS_UP | MYLK CFI FBXO46 TRIM10 FZD1 GTF2IRD2B PTPRD HPX GTF2IRD2 C1S CPSF2 HECTD1 CDH2 HERC4 DCBLD2 PLXNA2 | 4.48e-07 | 541 | 168 | 16 | MM1061 |
| Coexpression | PILON_KLF1_TARGETS_UP | MYLK CFI FBXO46 TRIM10 FZD1 GTF2IRD2B PTPRD HPX C1S CPSF2 HECTD1 CDH2 HERC4 DCBLD2 PLXNA2 | 9.40e-07 | 503 | 168 | 15 | M2226 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | EPHB3 FLNB CAND2 MYLK KMT2E APOBR MPRIP POSTN THBS1 GADD45G MACF1 LTBP2 MMP17 CDH2 PBXIP1 PLXNA2 EPHA5 EPHA7 | 9.71e-07 | 721 | 168 | 18 | M1999 |
| Coexpression | NABA_CORE_MATRISOME | LAMB4 COL12A1 SPOCK2 CHADL SSPOP POSTN THBS1 SPOCK3 PODN LTBP2 | 1.20e-05 | 275 | 168 | 10 | M5884 |
| Coexpression | WANG_SMARCE1_TARGETS_UP | 2.14e-05 | 294 | 168 | 10 | M1804 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 2.73e-05 | 135 | 168 | 7 | M5825 | |
| Coexpression | NABA_MATRISOME | HGF LAMB4 COL12A1 WNT3 ANXA7 SPOCK2 CHADL TGM6 SSPOP POSTN IFNW1 THBS1 SPOCK3 HPX PODN LTBP2 MMP17 PLXNA2 PLXNB1 | 3.42e-05 | 1026 | 168 | 19 | M5889 |
| Coexpression | DANG_REGULATED_BY_MYC_DN | 3.70e-05 | 251 | 168 | 9 | M2310 | |
| Coexpression | GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP | 4.21e-05 | 197 | 168 | 8 | M9725 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 4.68e-05 | 200 | 168 | 8 | M9463 | |
| Coexpression | GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN | 4.68e-05 | 200 | 168 | 8 | M3680 | |
| Coexpression | NABA_CORE_MATRISOME | 6.50e-05 | 270 | 168 | 9 | MM17057 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | FLNA SAAL1 STK17A TTC39C SRPK1 RCC1 SLC1A5 BRCA2 BOD1L1 CPSF2 HECTD1 CDH2 ATP2B1 HERC4 DCBLD2 | 6.66e-05 | 721 | 168 | 15 | M10237 |
| Coexpression | NABA_PROTEOGLYCANS | 7.30e-05 | 35 | 168 | 4 | M5882 | |
| Coexpression | MURARO_PANCREAS_ALPHA_CELL | FLNB CPNE8 ANXA7 PYROXD2 BCKDHB NOMO1 ARFGEF3 KLHL3 PTPRD GADD45G SPOCK3 HSD17B14 ATP2B1 | 8.06e-05 | 568 | 168 | 13 | M39168 |
| Coexpression | NABA_PROTEOGLYCANS | 8.17e-05 | 36 | 168 | 4 | MM17061 | |
| Coexpression | NABA_MATRISOME | HGF COL12A1 WNT3 ANXA7 SPOCK2 CHADL TGM6 SSPOP POSTN IFNW1 THBS1 SPOCK3 HPX PODN LTBP2 MMP17 PLXNA2 PLXNB1 | 8.82e-05 | 1008 | 168 | 18 | MM17056 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 1.01e-04 | 166 | 168 | 7 | M39026 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 1.04e-04 | 355 | 168 | 10 | M45758 | |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 1.24e-04 | 230 | 168 | 8 | M11563 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_MATURE_CELL | 1.37e-04 | 298 | 168 | 9 | M11205 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_UP | 1.45e-04 | 123 | 168 | 6 | M2080 | |
| Coexpression | DELYS_THYROID_CANCER_UP | EPHB3 BCAT1 SPOCK2 CFI SLC1A5 RYR1 THBS1 C2 CDH2 PCDH7 PLXNB1 | 1.48e-04 | 445 | 168 | 11 | M3645 |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 1.56e-04 | 178 | 168 | 7 | M17079 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_UP | 1.73e-04 | 127 | 168 | 6 | MM1289 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.76e-04 | 81 | 168 | 5 | M39253 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL12A1 DNAH10 KALRN OBSCN SSPOP ARFGEF3 PTPRD DNAH9 EPHA5 EPHA7 | 1.96e-09 | 184 | 166 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL12A1 DNAH10 KALRN OBSCN SSPOP ARFGEF3 PTPRD DNAH9 EPHA5 EPHA7 | 1.96e-09 | 184 | 166 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL12A1 DNAH10 KALRN OBSCN SSPOP ARFGEF3 PTPRD DNAH9 EPHA5 EPHA7 | 1.96e-09 | 184 | 166 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.78e-09 | 197 | 166 | 10 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.86e-08 | 188 | 166 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.04e-08 | 189 | 166 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.22e-08 | 190 | 166 | 9 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-08 | 191 | 166 | 9 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-08 | 191 | 166 | 9 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-08 | 195 | 166 | 9 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-08 | 195 | 166 | 9 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.76e-08 | 197 | 166 | 9 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.76e-08 | 197 | 166 | 9 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 6.02e-08 | 198 | 166 | 9 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 6.02e-08 | 198 | 166 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.28e-08 | 199 | 166 | 9 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.56e-08 | 200 | 166 | 9 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.56e-08 | 200 | 166 | 9 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.56e-08 | 200 | 166 | 9 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.56e-08 | 200 | 166 | 9 | ca777a7d001848f6d01c613ff2bda7e4f3e20521 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-08 | 200 | 166 | 9 | 105564ee05bd11685b5747ee32d5350cf3c2e2e1 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.56e-08 | 200 | 166 | 9 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 3.79e-07 | 179 | 166 | 8 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 3.95e-07 | 180 | 166 | 8 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.48e-07 | 183 | 166 | 8 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.48e-07 | 183 | 166 | 8 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 5.28e-07 | 187 | 166 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-07 | 188 | 166 | 8 | c300accbac71a3bc075fe985543d8a8ead82531b | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-07 | 189 | 166 | 8 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-07 | 189 | 166 | 8 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-07 | 189 | 166 | 8 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 5.95e-07 | 190 | 166 | 8 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-07 | 190 | 166 | 8 | 8a53f4d3c9aca45b5826f53f7dcdfb8bc8280acb | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.19e-07 | 191 | 166 | 8 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.19e-07 | 191 | 166 | 8 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.44e-07 | 192 | 166 | 8 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.44e-07 | 192 | 166 | 8 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-07 | 192 | 166 | 8 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-07 | 193 | 166 | 8 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.70e-07 | 193 | 166 | 8 | 88916d9a7d831eb52848599917c04238f8f9812b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.70e-07 | 193 | 166 | 8 | 800b0f5705fefcd3608e37801afae8a94474723e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-07 | 193 | 166 | 8 | 12f1333f11e6c262954ad7912d8fd2962ab06d25 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-07 | 193 | 166 | 8 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.70e-07 | 193 | 166 | 8 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.70e-07 | 193 | 166 | 8 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.70e-07 | 193 | 166 | 8 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.97e-07 | 194 | 166 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.97e-07 | 194 | 166 | 8 | 633fe72cc8a489abde12428e326478409ca03263 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.97e-07 | 194 | 166 | 8 | 87a86df0b542f287b0b20f4a4b1a37002271671d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.24e-07 | 195 | 166 | 8 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.24e-07 | 195 | 166 | 8 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.24e-07 | 195 | 166 | 8 | c51b1bee79e77aa2ac444a4883ef533c0095eaad | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.24e-07 | 195 | 166 | 8 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.24e-07 | 195 | 166 | 8 | 44f67437ea65d530133a0240b17f9860d9cc0e99 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.24e-07 | 195 | 166 | 8 | 43d372373367b71243c6ea958aedccde4478618f | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.53e-07 | 196 | 166 | 8 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.53e-07 | 196 | 166 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-07 | 196 | 166 | 8 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.82e-07 | 197 | 166 | 8 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.82e-07 | 197 | 166 | 8 | 4e0c3ea4f4a04a41532806edf3bccf7845c86fa5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.82e-07 | 197 | 166 | 8 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 7.82e-07 | 197 | 166 | 8 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.82e-07 | 197 | 166 | 8 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-07 | 197 | 166 | 8 | 87d09f53b84af482116d3e2076eab1a9e555a2a6 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-07 | 197 | 166 | 8 | 5bf5187fcba4ccc3f83bc9e884e40ff344a3d109 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 7.82e-07 | 197 | 166 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.12e-07 | 198 | 166 | 8 | b258f672529fb2c03e62e2696d335043c4963280 | |
| ToppCell | Severe-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.12e-07 | 198 | 166 | 8 | 8402421dc060926e968efe39a4e907f1e8ae5b1f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.12e-07 | 198 | 166 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.12e-07 | 198 | 166 | 8 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.12e-07 | 198 | 166 | 8 | c7075dce915ab8387309fcb12c5f6a17d4100cda | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.12e-07 | 198 | 166 | 8 | be305d89d48c67ce922fa71aaf15e24d00c89ff6 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.12e-07 | 198 | 166 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | COVID-19_Convalescent-PLT_3|World / Disease Group and Platelet Clusters | 8.43e-07 | 137 | 166 | 7 | bb54bb81b450462ad521b57e1a07a80ce1678e67 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-07 | 199 | 166 | 8 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.44e-07 | 199 | 166 | 8 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | distal-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.44e-07 | 199 | 166 | 8 | af226a6c50747dad9ca696463e715913b3ac17c0 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 8.44e-07 | 199 | 166 | 8 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.76e-07 | 200 | 166 | 8 | c5d818203bef80ff97c2e0158cf61970673dd258 | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.76e-07 | 200 | 166 | 8 | f09eaa52e11262ec47f3dcb4d890e240eaaa2b3d | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 200 | 166 | 8 | 8474e5d031d25bfb8461d39fa2053da01a6304fc | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 8.76e-07 | 200 | 166 | 8 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-06 | 167 | 166 | 7 | 78909f685ccd1321064eb0887caf9263e0e54879 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.42e-06 | 169 | 166 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.99e-06 | 173 | 166 | 7 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.31e-06 | 175 | 166 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.64e-06 | 177 | 166 | 7 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 5.37e-06 | 181 | 166 | 7 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-06 | 181 | 166 | 7 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-06 | 181 | 166 | 7 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.37e-06 | 181 | 166 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 5.37e-06 | 181 | 166 | 7 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 5.78e-06 | 183 | 166 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.78e-06 | 183 | 166 | 7 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | mild_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 5.78e-06 | 183 | 166 | 7 | 9a4899afac0f91203209392c5f67b3d0aa356b86 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 5.99e-06 | 184 | 166 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Mild/Remission-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.99e-06 | 184 | 166 | 7 | 3d4864605c812862cf8926e02370eea3b8ccf32f | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.99e-06 | 184 | 166 | 7 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.20e-06 | 185 | 166 | 7 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.20e-06 | 185 | 166 | 7 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| Drug | B-1,3-od | 1.51e-06 | 4 | 166 | 3 | CID011971053 | |
| Drug | BSSDA | 1.51e-06 | 4 | 166 | 3 | CID003081106 | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.93e-06 | 197 | 166 | 10 | 3940_UP | |
| Drug | Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A | SIPA1L3 BCAT1 EML2 KLHL3 R3HCC1L PTPRD HPX HSD17B14 DCBLD2 PBXIP1 | 1.93e-06 | 197 | 166 | 10 | 6383_DN |
| Drug | cobalt;(6E)-6-[[2-[[(E)-(6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]ethylamino]methylene]cyclohexa-2,4-dien-1-one;hydrate | 7.49e-06 | 6 | 166 | 3 | CID011810022 | |
| Drug | magnesium | RAD51C LAMB4 LPCAT1 PMS2 CNNM2 MYLK DNAH10 ANXA7 CTRB2 BCAT1 SRPK1 CCT7 BCKDHB SLC1A5 RYR1 PPP3R1 HASPIN C1S C2 FGFR1 CTRB1 HSD17B14 MMP17 ATP2B1 DNAH9 | 1.17e-05 | 1325 | 166 | 25 | CID000000888 |
| Drug | m-aminobenzamidine | 1.30e-05 | 7 | 166 | 3 | CID000197789 | |
| Drug | Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 7248_DN | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 6043_UP | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 4703_DN | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 2809_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 4592_DN | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; PC3; HT_HG-U133A | 1.61e-05 | 199 | 166 | 9 | 4564_DN | |
| Drug | DB07883 | 1.82e-05 | 75 | 166 | 6 | CID000446476 | |
| Drug | 3-doxylandrostanol | 3.10e-05 | 9 | 166 | 3 | CID000189075 | |
| Drug | BOCPheONP | 5.28e-05 | 2 | 166 | 2 | CID000111308 | |
| Drug | MPM-06 | 5.28e-05 | 2 | 166 | 2 | CID000161546 | |
| Drug | NSC-374899 | 5.28e-05 | 2 | 166 | 2 | CID000435726 | |
| Drug | methylbenzenebutanoate | 5.28e-05 | 2 | 166 | 2 | CID000281254 | |
| Drug | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu | 5.28e-05 | 2 | 166 | 2 | CID004418081 | |
| Drug | c189 | 5.28e-05 | 2 | 166 | 2 | CID000248048 | |
| Drug | dansyl-D-arginine methyl ester | 5.28e-05 | 2 | 166 | 2 | CID000191369 | |
| Drug | methyl 6-phenylhexanoate | 5.28e-05 | 2 | 166 | 2 | CID011820300 | |
| Drug | 5-aminotetrazole | 5.28e-05 | 2 | 166 | 2 | CID000020467 | |
| Drug | 2-bromoisobutyric acid | 5.28e-05 | 2 | 166 | 2 | CID000074924 | |
| Drug | p-toluamidine | 5.28e-05 | 2 | 166 | 2 | CID000122753 | |
| Drug | N-acetyl-alpha-azaphenylalanine phenyl ester | 5.28e-05 | 2 | 166 | 2 | CID000191275 | |
| Drug | isobutyl sulfide | 5.28e-05 | 2 | 166 | 2 | CID000011607 | |
| Drug | dimethylmaleic anhydride | 6.02e-05 | 11 | 166 | 3 | CID000013010 | |
| Drug | 26-nor-25-doxylcholestanol | 6.02e-05 | 11 | 166 | 3 | CID000125890 | |
| Drug | alpha-amyrin linoleate | 6.02e-05 | 11 | 166 | 3 | CID005318324 | |
| Drug | Prednisone [53-03-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 7.67e-05 | 189 | 166 | 8 | 4400_DN | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 8.56e-05 | 192 | 166 | 8 | 4144_DN | |
| Drug | Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 9.20e-05 | 194 | 166 | 8 | 4110_UP | |
| Drug | Methoxy-8-psoralen [298-81-7]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 9.20e-05 | 194 | 166 | 8 | 3302_UP | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 9.20e-05 | 194 | 166 | 8 | 4371_UP | |
| Drug | E1-P | 9.46e-05 | 33 | 166 | 4 | CID000104406 | |
| Drug | H2DIDS | 9.46e-05 | 33 | 166 | 4 | CID000115184 | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 6868_DN | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; PC3; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 5763_DN | |
| Drug | Dimethadione [695-53-4]; Down 200; 31uM; PC3; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 4607_DN | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; PC3; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 7147_DN | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 5541_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 3531_UP | |
| Drug | Dimethadione [695-53-4]; Down 200; 31uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 3367_DN | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 3803_UP | |
| Drug | Repaglinide [135062-02-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 7216_DN | |
| Drug | Fluocinonide [356-12-7]; Down 200; 8uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 3757_DN | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 4397_DN | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 2302_UP | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A | 1.10e-04 | 199 | 166 | 8 | 408_DN | |
| Drug | Primidone [125-33-7]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 3402_UP | |
| Drug | Ethosuximide [77-67-8]; Up 200; 28.4uM; PC3; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 7308_UP | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; PC3; HG-U133A | 1.10e-04 | 199 | 166 | 8 | 1935_DN | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 2235_UP | |
| Drug | ponatinib | 1.40e-04 | 68 | 166 | 5 | ctd:C545373 | |
| Drug | SB-C | 1.50e-04 | 69 | 166 | 5 | CID005331010 | |
| Drug | N-acetylbenzotriazole | 1.58e-04 | 3 | 166 | 2 | CID000087784 | |
| Drug | AC1L32J8 | 1.58e-04 | 3 | 166 | 2 | CID000133313 | |
| Drug | photophor | 1.58e-04 | 3 | 166 | 2 | CID000014780 | |
| Drug | dibutyl iodomethaneboronate | 1.58e-04 | 3 | 166 | 2 | CID000098591 | |
| Drug | zinc;dipicolinate | 1.58e-04 | 3 | 166 | 2 | CID004309911 | |
| Drug | 2-oxobut-3-ynoate | 1.58e-04 | 3 | 166 | 2 | CID000171547 | |
| Drug | AFMeq | 1.58e-04 | 3 | 166 | 2 | CID000194069 | |
| Drug | Bz-Cti-otbu | 1.58e-04 | 3 | 166 | 2 | CID006452691 | |
| Drug | n-(2-oxoethyl)benzamide | 1.58e-04 | 3 | 166 | 2 | CID000188995 | |
| Drug | AC1L49DM | 1.58e-04 | 3 | 166 | 2 | CID000152933 | |
| Drug | c140 | 1.58e-04 | 3 | 166 | 2 | CID002783250 | |
| Drug | Benzamidomethaneboronic acid | 1.58e-04 | 3 | 166 | 2 | CID000127677 | |
| Drug | phenyl hippurate | 1.58e-04 | 3 | 166 | 2 | CID000076323 | |
| Drug | FK-386 | 1.58e-04 | 3 | 166 | 2 | CID000135044 | |
| Drug | FK-375 | 1.58e-04 | 3 | 166 | 2 | CID000135042 | |
| Drug | carbostyril-124 | 1.58e-04 | 3 | 166 | 2 | CID000088277 | |
| Drug | N-trifluoroacetyl-4-fluorophenylalanine | 1.58e-04 | 3 | 166 | 2 | CID000328214 | |
| Drug | C18 4 | 1.58e-04 | 3 | 166 | 2 | CID000077248 | |
| Drug | taraxastane | 1.58e-04 | 3 | 166 | 2 | CID006429404 | |
| Drug | Phe-phe-ome | 1.58e-04 | 3 | 166 | 2 | CID000151728 | |
| Drug | phenylethaneboronic acid | 1.58e-04 | 3 | 166 | 2 | CID000065389 | |
| Drug | 3-amino-2-pyridone | 1.58e-04 | 3 | 166 | 2 | CID000322353 | |
| Drug | ASA-BMPA | 1.58e-04 | 3 | 166 | 2 | CID003035649 | |
| Drug | p-nitrophenyl benzoate | 1.58e-04 | 3 | 166 | 2 | CID000070396 | |
| Drug | endografin | 1.58e-04 | 3 | 166 | 2 | CID000019039 | |
| Drug | phthalocyanine blue | 1.58e-04 | 3 | 166 | 2 | CID000008978 | |
| Drug | tridodecylamine | 1.58e-04 | 3 | 166 | 2 | CID000007624 | |
| Drug | Z-Phe-OMe | 1.58e-04 | 3 | 166 | 2 | CID003082435 | |
| Drug | 3-methylcoumarin | 1.58e-04 | 3 | 166 | 2 | CID000017130 | |
| Drug | 2-propyl methylphosphonochloridate | 1.58e-04 | 3 | 166 | 2 | CID000102124 | |
| Drug | FK-316 | 1.58e-04 | 3 | 166 | 2 | CID000133688 | |
| Drug | AC1L19T8 | 1.58e-04 | 3 | 166 | 2 | CID000000694 | |
| Drug | Marinostatin D | 1.58e-04 | 3 | 166 | 2 | CID000132206 | |
| Drug | 1FD7 | 1.58e-04 | 3 | 166 | 2 | CID000445579 | |
| Drug | Glt-leu-phe-nh-meq | 1.58e-04 | 3 | 166 | 2 | CID000194914 | |
| Drug | AC1L4Z4F | 1.58e-04 | 3 | 166 | 2 | CID000194913 | |
| Drug | Glt-Phe-NH-FMeq | 1.58e-04 | 3 | 166 | 2 | CID000194912 | |
| Drug | diacetyl trimer | 1.58e-04 | 3 | 166 | 2 | CID000193527 | |
| Drug | FK-448 | 1.58e-04 | 3 | 166 | 2 | CID006917869 | |
| Drug | Ac-Phe-OMe | 1.58e-04 | 3 | 166 | 2 | CID000097805 | |
| Drug | thiobenzyl N-heptafluorobutyrylanthranilate | 1.58e-04 | 3 | 166 | 2 | CID000133906 | |
| Drug | AC1L2TMY | 2.40e-04 | 17 | 166 | 3 | CID000102826 | |
| Drug | kazinol B | 2.40e-04 | 17 | 166 | 3 | CID000480869 | |
| Disease | Malignant neoplasm of breast | RAD51C FLNA FLNB CTU2 PCDHGB6 KALRN OBSCN ELP1 CUBN ELP3 PHGDH THBS1 PTPRD TRMT2A BRCA2 MACF1 BOD1L1 FGFR1 CDH2 DNAH9 PLXNB1 | 6.63e-07 | 1074 | 165 | 21 | C0006142 |
| Disease | level of chymotrypsinogen B2 in blood serum | 3.11e-05 | 2 | 165 | 2 | OBA_2041192 | |
| Disease | Riley-Day syndrome (implicated_via_orthology) | 3.11e-05 | 2 | 165 | 2 | DOID:11589 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | RAD51C FLNA CTU2 PCDHGB6 ELP1 ELP3 PHGDH THBS1 PTPRD BRCA2 FGFR1 CDH2 | 4.28e-05 | 525 | 165 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | RAD51C FLNA CTU2 PCDHGB6 ELP1 ELP3 PHGDH THBS1 PTPRD BRCA2 FGFR1 CDH2 | 4.28e-05 | 525 | 165 | 12 | C1257931 |
| Disease | Mammary Neoplasms | RAD51C FLNA CTU2 PCDHGB6 ELP1 ELP3 PHGDH THBS1 PTPRD BRCA2 FGFR1 CDH2 | 4.44e-05 | 527 | 165 | 12 | C1458155 |
| Disease | Breast Carcinoma | RAD51C FLNA CTU2 PCDHGB6 ELP1 ELP3 PHGDH THBS1 PTPRD BRCA2 FGFR1 CDH2 | 5.41e-05 | 538 | 165 | 12 | C0678222 |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 9.29e-05 | 3 | 165 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 9.29e-05 | 3 | 165 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | chymotrypsinogen B measurement | 9.29e-05 | 3 | 165 | 2 | EFO_0801477 | |
| Disease | Glioma | 1.31e-04 | 87 | 165 | 5 | C0017638 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.56e-04 | 19 | 165 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | cortical thickness | FLNB CNNM2 COL12A1 CTTNBP2 ABCF3 WNT3 EML2 THBS1 DENND1B GADD45G STAU2 MACF1 MYEOV FGFR1 PCDH7 PLXNA2 EPHA7 | 1.77e-04 | 1113 | 165 | 17 | EFO_0004840 |
| Disease | prostate cancer (biomarker_via_orthology) | 1.85e-04 | 4 | 165 | 2 | DOID:10283 (biomarker_via_orthology) | |
| Disease | Hereditary breast ovarian cancer syndrome | 1.85e-04 | 4 | 165 | 2 | cv:C0677776 | |
| Disease | coronary artery disease (is_implicated_in) | 2.52e-04 | 100 | 165 | 5 | DOID:3393 (is_implicated_in) | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 3.07e-04 | 5 | 165 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | cognitive function measurement | PMS2P3 KALRN WNT3 NTRK3 PYROXD2 THSD7B KMT2E STRIP1 PTPRD PPP3R1 GADD45G SPOCK3 CPNE1 C2 CDH2 PCDH7 PREX1 EPHA5 EPHA7 | 4.40e-04 | 1434 | 165 | 19 | EFO_0008354 |
| Disease | MEDULLOBLASTOMA | 4.59e-04 | 6 | 165 | 2 | 155255 | |
| Disease | Medulloblastoma | 4.59e-04 | 6 | 165 | 2 | cv:C0025149 | |
| Disease | X-12112 measurement | 4.59e-04 | 6 | 165 | 2 | EFO_0800705 | |
| Disease | cortical surface area measurement | HGF FLNB CNNM2 CTTNBP2 WNT3 EML2 STRIP1 MPRIP THBS1 DENND1B GADD45G LACTB2 STAU2 MACF1 FGFR1 PCDH7 PLXNA2 EPHA7 | 5.57e-04 | 1345 | 165 | 18 | EFO_0010736 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | CNNM2 CTTNBP2 WNT3 NTRK3 ELP1 THSD7B SLC1A5 POSTN DENND1B PITPNM3 FGFR1 PCDH7 PLXNA2 | 5.97e-04 | 801 | 165 | 13 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Neoplasm Invasiveness | 6.11e-04 | 184 | 165 | 6 | C0027626 | |
| Disease | age-related macular degeneration, COVID-19 | 6.14e-04 | 69 | 165 | 4 | EFO_0001365, MONDO_0100096 | |
| Disease | Breast Cancer, Familial | 6.24e-04 | 30 | 165 | 3 | C0346153 | |
| Disease | Malignant Glioma | 6.49e-04 | 70 | 165 | 4 | C0555198 | |
| Disease | mixed gliomas | 6.49e-04 | 70 | 165 | 4 | C0259783 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 6.84e-04 | 71 | 165 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | Large cell carcinoma of lung | 7.56e-04 | 32 | 165 | 3 | C0345958 | |
| Disease | Complement deficiency disease | 8.28e-04 | 33 | 165 | 3 | C0272242 | |
| Disease | N2,N2-dimethylguanosine measurement | 8.51e-04 | 8 | 165 | 2 | EFO_0021125 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 8.51e-04 | 8 | 165 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | Disproportionate short stature | 9.29e-04 | 77 | 165 | 4 | C0878659 | |
| Disease | Dermatitis, Irritant | 1.09e-03 | 9 | 165 | 2 | C0162823 | |
| Disease | Glioma | 1.09e-03 | 9 | 165 | 2 | cv:C0017638 | |
| Disease | Glaucoma | 1.09e-03 | 9 | 165 | 2 | C0017601 | |
| Disease | heart rate variability measurement | 1.16e-03 | 37 | 165 | 3 | EFO_0008003 | |
| Disease | atherosclerosis (is_marker_for) | 1.16e-03 | 37 | 165 | 3 | DOID:1936 (is_marker_for) | |
| Disease | executive function measurement | 1.31e-03 | 376 | 165 | 8 | EFO_0009332 | |
| Disease | medulloblastoma (is_implicated_in) | 1.36e-03 | 10 | 165 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | Kunitz-type protease inhibitor 2 measurement | 1.36e-03 | 10 | 165 | 2 | EFO_0008200 | |
| Disease | adseverin measurement | 1.36e-03 | 10 | 165 | 2 | EFO_0801358 | |
| Disease | Neoplasm Metastasis | 1.43e-03 | 217 | 165 | 6 | C0027627 | |
| Disease | multiple system atrophy | 1.46e-03 | 40 | 165 | 3 | EFO_1001050 | |
| Disease | trypsin-2 measurement | 1.65e-03 | 11 | 165 | 2 | EFO_0008305 | |
| Disease | Autoimmune Diseases | 1.68e-03 | 42 | 165 | 3 | C0004364 | |
| Disease | prostate cancer (is_marker_for) | 1.88e-03 | 156 | 165 | 5 | DOID:10283 (is_marker_for) | |
| Disease | autistic disorder (is_marker_for) | 1.98e-03 | 12 | 165 | 2 | DOID:12849 (is_marker_for) | |
| Disease | Fanconi anemia | 2.71e-03 | 14 | 165 | 2 | cv:C0015625 | |
| Disease | wet macular degeneration | 2.71e-03 | 14 | 165 | 2 | EFO_0004683 | |
| Disease | cerebellum cortex volume change measurement | 2.71e-03 | 14 | 165 | 2 | EFO_0021497 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 2.71e-03 | 14 | 165 | 2 | C0677776 | |
| Disease | N,N,N-trimethyl-5-aminovalerate measurement | 3.11e-03 | 15 | 165 | 2 | EFO_0800090 | |
| Disease | Small cell carcinoma of lung | 3.46e-03 | 54 | 165 | 3 | C0149925 | |
| Disease | neutrophil collagenase measurement | 3.54e-03 | 16 | 165 | 2 | EFO_0008248 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 3.54e-03 | 16 | 165 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 3.54e-03 | 16 | 165 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | asthma, response to diisocyanate | 3.59e-03 | 261 | 165 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | brain aneurysm | 3.78e-03 | 113 | 165 | 4 | EFO_0003870 | |
| Disease | Vascular Diseases | 4.00e-03 | 17 | 165 | 2 | C0042373 | |
| Disease | creatine kinase measurement | 4.44e-03 | 59 | 165 | 3 | EFO_0004534 | |
| Disease | Age-related macular degeneration | 4.48e-03 | 18 | 165 | 2 | cv:C0242383 | |
| Disease | Bone marrow hypocellularity | 4.48e-03 | 18 | 165 | 2 | C1855710 | |
| Disease | response to vaccine | 4.97e-03 | 122 | 165 | 4 | EFO_0004645 | |
| Disease | superior temporal gyrus volume measurement | 4.99e-03 | 19 | 165 | 2 | EFO_0010331 | |
| Disease | aspartate aminotransferase measurement | FLNB KALRN WNT3 PYROXD2 OBSCN THSD7B CUBN NUBP2 PTPRD NUP37 CPNE1 AKAP13 | 5.01e-03 | 904 | 165 | 12 | EFO_0004736 |
| Disease | cholangiocarcinoma (is_marker_for) | 5.57e-03 | 64 | 165 | 3 | DOID:4947 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGEFVDVFGNATERC | 11 | A6NGE7 | |
| VCIADEVQTGFGRLG | 316 | Q9BYV1 | |
| CGVRTSDVVVAGEFD | 76 | Q6GPI1 | |
| SCTVLNVEGDALGAG | 466 | Q15758 | |
| TGEDEVGCAGFASVT | 286 | P05156 | |
| VGCAGFASVTQEETE | 291 | P05156 | |
| ICAGESFQVVVRGNG | 231 | Q9H6X2 | |
| ECTGEGGSKEVVGTF | 11 | P54687 | |
| EGIQAEFVGGVLVCN | 731 | Q9P2I0 | |
| ETQLFCEQGDGGTEG | 196 | P02730 | |
| DDVCQGNGVVVTQFG | 1181 | Q96Q42 | |
| TIERVIGAGEFGEVC | 676 | P54756 | |
| VAEGQCQRGSEIVAG | 411 | P28799 | |
| DLESRICVVGENGAG | 516 | Q9NUQ8 | |
| EEATGSLAGCFAGRE | 1316 | Q12802 | |
| GSSICEGTVEVRQGA | 281 | P06127 | |
| QAGEGRLGTDESCFN | 351 | P20073 | |
| GRISFEEFCAVVGGL | 146 | P63098 | |
| GVDPARVVVCGDSFG | 181 | Q5VUY0 | |
| RVVVCGDSFGGAIAA | 186 | Q5VUY0 | |
| GDSFGGAIAAVVCQQ | 191 | Q5VUY0 | |
| VVTSGCLGLEGSDFQ | 66 | O00238 | |
| EGDNALCGEVSVGEE | 131 | P20020 | |
| ECTSVFSRGGGEELA | 201 | Q9Y5Y2 | |
| CVDFEVESVGGIANS | 281 | Q7Z5L2 | |
| ECFGGVAGEAVFIDT | 146 | O43502 | |
| FGCNDEGALGRDTSV | 91 | P18754 | |
| GSEDIVVGCGGFVKS | 31 | P69849 | |
| AESCLEETGGLGVDI | 206 | O95825 | |
| GAVNLIESGACGAFV | 366 | Q96HW7 | |
| FGGNGEVRCNIETDI | 376 | Q9Y5F9 | |
| EDVAFGGVFRCTVGL | 96 | P21953 | |
| QEGVVDCGGIDLREF | 76 | Q7Z5L7 | |
| GSEDIVVGCGGFVKS | 31 | Q5JPE7 | |
| QEDGSVGEGDLSCIL | 431 | Q8NF37 | |
| EGAGQAVESECAVLA | 341 | Q460N3 | |
| DDVGVYTCLVVNGSG | 226 | Q15746 | |
| NQCTDVVDGEGRTGQ | 101 | Q6WCQ1 | |
| GTIFEGIDCVIFATG | 316 | P31513 | |
| QATVGEEGGVARFQC | 146 | Q8IVU1 | |
| VREGDNAVITCNGSG | 221 | Q16288 | |
| GNVSFECEDGFILRG | 111 | P06681 | |
| EGEEQRLCEGVGSVN | 411 | O43790 | |
| VVTGQLGDEGEQCSA | 221 | P49005 | |
| TVDCTEAGEGDVSVG | 766 | O75369 | |
| GIACAFGNLTEVEGQ | 591 | O75051 | |
| LVCITGASGEEVAGA | 1126 | O43157 | |
| TGVVDECIFFGKDGT | 371 | Q6PJ61 | |
| EENAIFSGDCILGEG | 156 | Q53H82 | |
| FSGDCILGEGTTVFE | 161 | Q53H82 | |
| DQGENGVVTCTVVGD | 451 | O60245 | |
| EIVGSCGGGVDSSQF | 216 | Q719H9 | |
| VEEGSSAERAGLCVG | 116 | Q9H5P4 | |
| GEDIVLQCAVNEGSG | 516 | P16284 | |
| DSDGQLGLVGSEECI | 111 | Q5GLZ8 | |
| GGCELTVVLQDFSAG | 1646 | O60229 | |
| GSEDIVVGCGGFVKS | 31 | Q15155 | |
| AVREVGDVTCGNGET | 511 | Q96LU7 | |
| GDVTCGNGETLENFL | 516 | Q96LU7 | |
| NGCGVEEENFEGLIS | 146 | Q13401 | |
| LIEVSGNGCGVEEEN | 211 | Q13670 | |
| VFCTSEDGLVSGFGR | 1121 | Q8IZD2 | |
| GNGEECIERVTFSFA | 641 | O94854 | |
| GEAFRVGVEQAISSC | 166 | Q96EZ4 | |
| EEVIGAGEFGEVCRG | 636 | P54753 | |
| CGEGSISVGENVSDV | 1336 | Q96RT7 | |
| RGDGQFFAVSVVCPE | 201 | O95163 | |
| VQCFGLEQGGLFVEA | 141 | Q641Q3 | |
| FTGCTQVVDVGSGQG | 151 | Q96FB5 | |
| ETTECIQGQGEGYRG | 301 | P14210 | |
| IEVSGNGCGVEEENF | 266 | A4D2B8 | |
| NGCGVEEENFEGLTL | 271 | A4D2B8 | |
| IGTCTFQEEEADVEG | 46 | Q8NFH4 | |
| EGRDGGGLVAQCTVE | 316 | Q9Y5G0 | |
| HGDCEDVFLDQVVGG | 1481 | Q8NDA8 | |
| ERVIGAGEFGEVCSG | 636 | Q15375 | |
| DCGSSINGVAVGAAD | 216 | Q9BRP4 | |
| DQIGVSGGVASFVCQ | 41 | Q13332 | |
| STVVAEEGGEATFQC | 1906 | Q5VST9 | |
| SECTVFAAAEEGGAV | 1581 | Q8NFC6 | |
| FTDCGGIQIGDSGVI | 2686 | O60494 | |
| GQVDGDVLSGVCFVG | 466 | Q9UP38 | |
| NKVEGDNISGVCFVG | 346 | O60353 | |
| SIGTVGTQDVDCDFI | 46 | Q9BSB4 | |
| CTRESGAVFEAGGLN | 131 | Q9ULT8 | |
| TCLLQVVGEGESAGA | 121 | P05000 | |
| TELRSDFQCVVGFGG | 291 | Q53GT1 | |
| SSLFSDGGNVGCVDV | 2806 | P51587 | |
| VCSGVDEQLGELVSG | 316 | Q99715 | |
| AGFSCEIVRAEVDAG | 1151 | Q8WZ74 | |
| EGCFGQVVLAEAIGL | 486 | P11362 | |
| ERATAGEVGQFQVDC | 1171 | P21333 | |
| NVTFCVLAAGEEDEG | 56 | O95257 | |
| SGTESFSGEGCQVRV | 1631 | Q5TH69 | |
| CLDGFEVVEGRVGAT | 321 | P09871 | |
| LGFDTCGQEITEATG | 466 | P43251 | |
| QAITGQVGFVDVEFC | 306 | Q8IV38 | |
| CSEETFRFELGGGVS | 456 | Q9H9T3 | |
| LVGADVCGFLGNTSE | 641 | P10253 | |
| GFVSAEGGTSCQDVD | 1206 | Q14767 | |
| SGEVCNRTEGFIGLN | 546 | Q8TF76 | |
| NFCTGIELLVTGGAE | 236 | Q9BPX1 | |
| ASDEGEVIVFGGCAN | 326 | Q9Y2U9 | |
| VVGGDDGSCNLASVE | 541 | Q9UH77 | |
| TSGQAQGVGDIVCDS | 171 | A4D0S4 | |
| AFKVEGGQFGSVEEC | 361 | P11279 | |
| GGQFGSVEECLLDEN | 366 | P11279 | |
| LCVTFLEGGDVVTGD | 256 | O95834 | |
| TQEVSGAGRDGECDV | 756 | Q96PD2 | |
| SLESGVKGGFCDIVE | 936 | Q9NYC9 | |
| IGTENVCFVETDGRG | 231 | Q6ZQY3 | |
| CEVELVAEGAFRGLG | 96 | Q6NUI6 | |
| ETDVFVVGTERGCAF | 51 | Q86UP8 | |
| ETDVFVVGTERGCAF | 51 | Q6EKJ0 | |
| EGAEEGTRGVVAECI | 946 | O75155 | |
| VFEEEITSGGFCGGN | 401 | Q6P3S1 | |
| DEVNERAGQGCFVSG | 4366 | Q8IVF4 | |
| EEEEVAGGDCIGSTV | 16 | Q96ER3 | |
| AFDVGLQEDATGEAC | 131 | P21817 | |
| NGDCTDVDRIVGAGL | 706 | P19022 | |
| DFLGQVFCTLGEIVG | 111 | Q86YQ8 | |
| FVAGVIFVDEGAACG | 106 | Q2VPK5 | |
| CGVRTSDVVVAGEFD | 76 | P17538 | |
| DDFLGGAECSLGQIV | 91 | Q99829 | |
| GFCSAGVQTEAGVAD | 71 | Q9BQA1 | |
| VDQTGVSGGVASFIC | 31 | P23468 | |
| ETQTQRGGEFQCGLE | 301 | Q86T96 | |
| RGECQAEGVLFFQGD | 151 | P02790 | |
| TAVFGVEGEVCGVRL | 176 | Q8TDU9 | |
| LVGVGVDGEDNTVGC | 246 | Q8IZ69 | |
| GSESGCLDAVEVAQG | 356 | A2VEC9 | |
| ICGEGTPQATGFFEV | 36 | P63302 | |
| LVCGDSQADGSVAAG | 521 | Q9ULZ9 | |
| DLIEVSGNGCGVEEE | 126 | O95744 | |
| SGNGCGVEEENFEGL | 131 | O95744 | |
| GDCQTREEAVALGVG | 556 | Q8TCU6 | |
| VAQGTFGECSSEAEV | 151 | Q5VSL9 | |
| GVDLAASCGARVGDV | 11 | O60292 | |
| VLGRCQVFEETQIGG | 341 | Q99832 | |
| EVARCVDAGSFEQGL | 1131 | Q9NQW1 | |
| DTEGGAAEINCNGVI | 346 | Q96SB4 | |
| CLGGQVVHDDFGEVT | 931 | Q9BVR0 | |
| GGELCGVDVDQDGET | 461 | P20701 | |
| QLVDSAGSECVGVSG | 266 | Q9UIL4 | |
| FVTGDCSEAGLVDDV | 91 | Q8WUJ1 | |
| EGDAFELTVSCQGGL | 506 | P40967 | |
| EVRFLCDEGAGISGD | 191 | Q13438 | |
| AAGGEIFDQCVADRE | 141 | Q9UEE5 | |
| LTTQDAGCGTEEGEA | 681 | Q0VD83 | |
| AGCGTEEGEASVSEN | 686 | Q0VD83 | |
| GGCAAVGENEETVII | 61 | Q9H8M5 | |
| NVFEATVSCVGDDGT | 1181 | Q9BXT8 | |
| FGGKDCVGDVTENQI | 526 | P07996 | |
| DAGELTCVGQGTVTF | 1261 | Q96KV7 | |
| VDECARQEGLTFFGT | 591 | Q96AQ6 | |
| TRVSVGEFSAEGEGN | 241 | Q9NUL3 | |
| VNSEGCVQGVVLEDG | 316 | Q8N2H3 | |
| GGCSEDADFGVLVSR | 156 | P56703 | |
| CESKEGGQGEETFSQ | 71 | Q7L945 | |
| EEAGEGCVAAILGET | 51 | Q96DC7 | |
| GCVAAILGETEVQQF | 56 | Q96DC7 | |
| NEVIGVCRTGLDAEG | 461 | Q6XYQ8 | |
| SDGIGFSGQVCLIGD | 251 | Q9BZ71 | |
| GSRINGVADCAIDFE | 371 | Q9BQ16 | |
| NGCGVEEENFEGLTL | 71 | P54278 | |
| VPGGTETGDVCEDTF | 81 | Q6ZMS4 | |
| GGSCTVGVVSEDVQR | 376 | Q9UDY6 | |
| NGFEAVEAEGSAGCR | 6 | Q9H5U6 | |
| EIAESCLFQEGGFGR | 71 | Q8TBZ5 | |
| SGQCAGAALDVFTEE | 251 | O43175 | |
| RCVNTADGEGGAVDS | 1091 | Q9C0I4 | |
| EGGARGVGDVQETCL | 786 | Q5JPB2 | |
| VCQGATGDVDGAQIV | 396 | Q8N584 | |
| FETLEGNTIEIGCDG | 321 | Q15063 | |
| GNTIEIGCDGDSITV | 326 | Q15063 | |
| DATPQEESEGVFRCG | 356 | O95932 | |
| CDDIVGFSGDFGSGV | 376 | Q92563 | |
| QEEGAEIQCEAETGG | 196 | Q9UNY4 | |
| VTGEGTSFRVEGLCA | 191 | Q8NBZ9 |